Photo shows the company logo on the headquarters of Danish biotech company Bavaria Nordisk in Hellerup, north of Copenhagen.
Liselotte Sabroe | Liselotte Sabroe AFP | Getty Images
Shares of Danish biotech Bavarian Nordic rose more than 12% in early trading on Thursday after the company reported stronger-than-expected earnings and announced that it had acquired 100,000 euros from an unnamed European country amid the current MPOX outbreak. Massive vaccine orders.
Bavaria Nordic report Second-quarter revenue was 1.43 billion Danish kroner ($213 million) and operating profit was 420 million Danish kroner, higher than analysts’ expectations cited by Reuters.
The stock was up 12.5% as of 9:24 a.m. London time.
in a statement On Wednesday, the company also said it had received a contract for 440,000 doses to supply MPOX and smallpox vaccines to an unnamed European country.
The order comes after the World Health Organization declared mpox a global public health emergency last week after the outbreak in the Democratic Republic of Congo (DRC) spread to neighboring countries.
This is a breaking news story. Please check back for updates.
About The Author
